HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA Going Through Enforcement Toolkit To Address Bentonite Me Baby

This article was originally published in The Rose Sheet

Executive Summary

FDA lab analysis found lead in Alikay Naturals' Bentonite Me Baby clay at a level of 37.5 ppm, according to a March 16 warning letter citing the purported cosmetic as an unapproved and misbranded drug. The agency cautioned consumers about the product in January and seems to be urging the company to recall it, which may draw attention to the authority FDA currently lacks under federal food, drug and cosmetic law.


Related Content

FDA Issues Second Warning This Year For Bentonite Clay Lead, Claims
Feinstein, EWG Gunning For Spring Senate Hearing On Cosmetics Bill
FDA Warns Public About Products Posing Heavy-Metal Exposure Risks
FDA Issues Final Lead-In-Lipstick Report, Postpones Decision On Cosmetic Lead Limits





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts